The file's text, extracted by GovTribe without its formatting.
36C26223Q1559
| SUBJECT* |
| Compounded Chemotherapy Medications - VA Long Beach |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 90815 |
| SOLICITATION NUMBER* |
| 36C26223Q1559 |
| RESPONSE DATE/TIME/ZONE |
| 09-08-2023 11:00 PACIFIC TIME, LOS ANGELES, USA |
| ARCHIVE |
| 90 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
Network Contracting Office 22 4811 Airport Plaza Drive Suite 600 Long Beach CA 90815
POINT OF CONTACT*
Contracting Specialist Adrienne Brown adrienne.brown4@va.gov
PLACE OF PERFORMANCE
| ADDRESS |
| Department of Veteran Affairss |
VA Long Beach Healthcare System
5901 East 7th Street
Long Beach CA
ADDITIONAL INFORMATION
| AGENCY’S URL |
| https://www.va.gov |
| URL DESCRIPTION |
| Department of Veteran Affairs |
| AGENCY CONTACT’S EMAIL ADDRESS |
| adrienne.brown4@va.gov |
| EMAIL DESCRIPTION |
| Contracting Specialist |
DESCRIPTION
This is a combined synopsis/solicitation and is unrestricted for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26223Q1559
The Department of Veterans Affairs Long Beach Healthcare System, Long Beach, CA 90822 has a requirement for Compounded Chemotherapy Medication. The Contractor shall furnish all supplies/services at The VA Long Beach Healthcare System located at 5901 East 7th Street, Long Beach, CA 90822.
Shipping included in cost.
NOTE: Potential offers must be aware that the items being acquired are procured as Brand Name or Equal. For those items that are “or equal”, a description of the salient characteristics are outlined below. The FAR Clause 52.211-6 Brand Name or Equal applies to this acquisition. Any items quoted as equal not confirming to the requirements of clause 52.211-6 will be considered non- responsive and not considered for award.
No remanufactures or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM.
| Item # |
| Description/Part Number* |
| Qty |
| UOM |
| 0001 |
| Compounded Chemotherapy Medications |
| 52 |
| WK |
The solicitation will be in accordance with FAR Part 12, 13, and 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412, Size Standard 1,300 Employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award. Due to time constraints, responses to the solicitation shall be due on Friday, September 8, 2023 at 11:00 AM PT Local Time. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Correspondence or questions may be directed to Adrienne Brown, Contracting Officer at ADRIENNE.BROWN4@va.gov with "36C26223Q1559, VA LB COMPOUNDED CHEMOTHERAPY MEDICATIONS” in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired.
Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice
| *= Required Field |
| Combined Synopsis/Solicitation Notice |
Combined Synopsis/Solicitation Notice
Table of Contents
| SECTION B - CONTINUATION OF COMBINED SYNOPSIS | 5 |
| B.1 CONTRACT ADMINISTRATION DATA | 5 |
| B.2 STATEMENT OF WORK | 6 |
| B.3 PRICE/COST SCHEDULE | 19 |
| ITEM INFORMATION | 19 |
| B.4 DELIVERY SCHEDULE | 19 |
| SECTION C - CONTRACT CLAUSES | 20 |
| C.1 52.204-27 PROHIBITION ON A BYTEDANCE COVERED APPLICATION (JUN 2023) | 20 |
| C.2 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022) | 21 |
| C.3 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) | 27 |
| C.4 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018) | 27 |
| C.5 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018) | 28 |
| C.6 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) | 29 |
| C.7 VAAR 852.247-71 DELIVERY LOCATION (OCT 2018) | 29 |
| C.8 VAAR 852.247-72 MARKING DELIVERABLES (OCT 2018) | 29 |
| C.9 VAAR 852.247-73 PACKING FOR DOMESTIC SHIPMENT (OCT 2018) | 30 |
| C.10 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (JUN 2023) | 30 |
| SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS | 39 |
| SECTION E - SOLICITATION PROVISIONS | 40 |
| E.1 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021) | 40 |
| E.2 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018) | 43 |
| E.3 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAR 2023) | 44 |
| E.4 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (NOV 2021) | 48 |
| E.5 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022) | 49 |
| E.6 52.216-1 TYPE OF CONTRACT (APR 1984) | 66 |
| E.7 52.233-2 SERVICE OF PROTEST (SEP 2006) | 67 |
| E.8 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998) | 67 |
| E.9 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018) | 68 |
SECTION B - CONTINUATION OF SF 1449 BLOCKS
B.1 CONTRACT ADMINISTRATION DATA
1. Contract Administration: All contract administration matters will be handled by the following individuals:
a. CONTRACTOR: TBD
b. GOVERNMENT: Contracting Officer 36C262 Department of Veterans Affairs Network Contracting Office 22 4811 Airport Plaza Drive Suite 600 Long Beach CA 90815
2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:
| [X] |
| 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or |
| [] |
| 52.232-36, Payment by Third Party |
3. INVOICES: Invoices shall be submitted in arrears:
| a. Quarterly | [] |
| b. Semi-Annually | [] |
| c. Other | [X] Monthly |
4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.
https://www.tungsten-network.com ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:
Page 1 of Page 1 of Page 1 of Page 1 of
B.2 STATEMENT OF WORK
STATEMENT OF WORK
1. SCOPE
VA Long Beach Healthcare System (VALBHS) is seeking a vendor able to provide the manufacturing and delivery of compounded chemotherapy drugs from an FDA 503A-compliant facility for the treatment of patients receiving services at the VA Long Beach Healthcare System. The period of performance shall be October 1, 2023 thru September 30, 2024 and items will be ordered as needed by VA Long Beach Pharmacy.
PARTICIPATING VA HEALTHCARE SYSTEMS:
VA Long Beach Healthcare System 5901 East 7th Street Long Beach, CA 90822
2. ROUTINE ORDERS
All medications must be delivered with no less than 12 hours remaining on the Beyond-Use-Date (BUD) and no sooner than 0600 AM PST/PDT on the date of delivery to allow adequate time for the administration to clinic patients during their regularly scheduled appointments.
3. EMERGENCY ORDERS
An emergency delivery requires same day delivery and with the time specified during the placement of order.
4. DELIVERY LOCATION, NORMAL WORK HOURS AND INSTRUCTIONS:
VA LONG BEACH HEALTHCARE SYSTEM:
Delivery Location – Radiology/Nuclear Medicine Imaging Service, Building 126, Room E119, 1st Floor Normal Work Hours – 6:00am to 4:00pm, Monday through Friday Instructions –
1) Isotopes arriving during normal work hours shall be delivered to the delivery location.
2) Isotopes arriving outside normal work hours, on weekends, or holidays, shall be delivered to the Ambulatory entrance of Bldg. 126 (main building facing 7th St) and must be signed for by the Medical Administrative Officer on duty. Isotopes are not to be left with the Telephone Operator or at the information desk at the lobby.
5. UNIT DOSE ITEMS
For unit-dose items, products shall be pre-drawn into a syringe, calibrated and delivered at time specified when ordered. The word “Dose” represents the maximum size potency per unit price; however, order may be less.
6. PACKAGING AND MARKING
a) The contractor shall package, mark and transfer all radioactive material in accordance with all applicable local, state, and federal regulations.
b) Items must be adequately packaged to prevent damage during shipping, handling, and storage.
c) All outer packages must contain the complete purchase number, obligation number and contract number in addition to the shipping address. The purchase number and obligation number will be provided by the individual at the time of ordering. The contract number will be provided upon notice of contract award.
d) Packaging List: A packing list/slip shall be enclosed with each shipment indicating the purchase/obligation and delivery order number, contract number, items/quality ordered and items/quality shipped.
e) The temperature logger must be included in shipments to monitor temperature of drugs for quality assurance. Shipping fees must be inclusive (cost per week) within the hazardous compounded chemotherapy drug.
7. RECALLED AND DEFECTIVE PRODUCTS
The Contractor will immediately notify the hospital and Contracting Officer (CO) of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled / defective products at no cost to the Government. The Contractor is responsible for costs of processing recalls to replace recalled/defective products.
8. CERTIFICATION AND LICENSING REQUIREMENT
Pharmacists employed by the Contractor shall be an authorized user on the Contractor’s Radioactive Materials License. The Pharmacy of the Contractor shall be licensed by the State of Operation and by the Nuclear Regulatory Commission or Agreement State Agency.
9. SAFETY GUIDELINES AND REQUIREMENTS
Delivery personnel shall be trained in Radiation Safety Techniques, Nuclear Regulatory Commission, Joint Commission safety guidelines and Department of Transportation requirements.
10. NATIONAL HOLIDAYS OBSERVED BY THE GOVERNMENT
https://www.opm.gov/policy-data-oversight/pay-leave/federal-holidays/ The President of the United States of America may declare additional days as a Federal holiday, and if so, this holiday will automatically be added to the referenced site above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday.
11. CONTRACTOR DELIVERY PERSONNEL
· All contractor personnel are required to wear clothing bearing the name of the Contractor and wear a badge that has the Contractor name. Contractor personnel must have a picture I.D. and must be able to speak English.
· Contractor shall provide the hospital point of contact with a list of contractor personnel expected to enter the buildings. While on VALBHCS premises or off-site parking locations, all contractor personnel shall comply with the rules, regulations, and procedures governing the conduct of personnel and the operation of the facility.
· Contractor personnel shall comply will all VALBHCS policies regarding health and security measures to enter VALBHCS facility. Measures may include but are not limited to answering health screening questions, having temperature taken, or any other measures PVAHCS may use to maintain health and safety of public entering facility.
· Current policies shall be distributed and updated as needed by the hospital point of contact.
· It is the responsibility of the contractor’s personnel to park in the appropriate designated parking areas. Parking information shall be coordinated with facility point of contact.
· VALBHCS shall not validate or make reimbursement for parking violations of the contractor’s personnel under any circumstance.
· Contractor shall comply with all security policies/requirements. All security policies/requirements must be met, and personnel cleared prior to the contractor performing work under this contract. Personnel that cannot meet the security and clearance requirements shall not be allowed to perform work under this contract.
12. Identification, Parking, Smoking, and VA Regulations:
Contractor personnel shall wear visible identification issued by VALBHCS Police Section at all times while on the premises of VALBHCS. It is the responsibility of the Contractor to park in the appropriate designated parking areas. Information on parking is available from the VA Police Section. VALBHCS will not invalidate or make reimbursement for parking violations of the Contractor under any conditions. Smoking is prohibited inside any buildings at VALBHCS. Contractor may smoke in designated smoking area on premises. Possession of weapons is prohibited. Enclosed containers, including tool kit, shall be subject to search. Violations of VA regulations may result in citation answerable in the United States (Federal) District Court, not a local district, state, or municipal court.
13. PLACEMENT OF VERBAL ORDERS
Contractors shall provide on a separate sheet of paper, the name, location, and telephone number of the office where the participating VA facility will call to place orders.
15. PERSONNEL POLICY
The parties agree that the contract personnel working this contract shall not be considered VA employees for any purpose and shall be considered employees of the contractor.
The government is seeking a vendor able to provide the manufacturing and delivery of compounded chemotherapy drugs from an FDA 503A-compliant facility for the treatment of patients receiving services at the VA Long Beach Healthcare System.
Vendor shall provide proof of required licensing and certification at the time of bid submission.
Salient Characteristics
· The Vendor must be able to compound and provide the hazardous medications, including supportive medications, for the VA Long Beach Pharmacy; approximately thirty patients on any given day throughout the performance period. The medications required are included in, but not limited to, the list below.
· All medications must be delivered with no less than 12 hours remaining on the Beyond-Use-Date (BUD) and no sooner than 6 AM PST/PDT on the date of delivery to allow adequate time for the administration to clinic patients during their regularly scheduled appointments.
· Vendor must have a certified 503A pharmacy(s) with an active board of pharmacy license that are licensed to ship into/within the State of California.
· The vendor must complete and meet all requirements for national VA Pharmacy Benefits Management (PBM) Compounded Sterile Products Assessment guidelines.
· The vendor must be able to provide documentation of compliance with the standards outlined in the current version of USP 797.
· The vendor must provide any current or past survey or inspection results and responses from the Joint Commission, Board of Pharmacy, FDA, or any other governing body.
· The vendor must be able to provide stability data for all medications upon request.
· Medications shall not be delivered until ordered by the authorized point of contract.
· Vendor shall notify the government of any anticipated shortages, recalls, or discontinuation of the medications.
· Vendor must be able to ensure and provide documentation that medications are handled appropriately per the manufacturer’s specifications prior to the receipt of the medication by VA Long Beach.
· Medications must meet the technical specifications stated in the FDA-approved package.
· Medication must be stored and used according to the directions on the labeling. If deviating from the FDA-approved package insert, the vendor must submit supporting evidence of practice and must be approved by the government before implementation.
Must be able to supply and deliver all compounded chemotherapy medications listed below.
| Abatacept |
| Orencia 125mg 4/box |
| Abatacept |
| Orencia Click-Jet 125mg 4/box |
| Abobotulinumtoxin A |
| Dysport 500u |
| Adalimumab |
| Humira 40mg/0.8ml Pen 2/box |
| Ado-trastuzumab emtansine |
| Kadcyla 100mg/15ml |
| Ado-trastuzumab emtansine |
| Kadcyla 160mg/20ml |
| Alteplase |
| Cathflo Activase 2mg |
| Amifostine |
| Amifostine 500mg via-l 3/bx |
| Amikacin |
| Amikacin Sulfate PF 500mg/2ml 10/box |
| Amphotericin B |
| Amphotericin B 50mg |
| Arginine |
| R-Gene HCL 300ml |
| Aripiprazole |
| Ability Maintena 400mg Syringe |
| Arsenic |
| Trisenox 10mg 10/box |
| Arsenic |
| Trisenox 12mg 10/box |
| Asparaginase Erwinia |
| Erwinaze 10,000iu/vi - Svl/box |
| Atezoliumab |
| Tecentriq 60mg/ml 20ml |
| Atropine |
| Atropine 0.4mg/ml 25/box |
| Atropine |
| Atropine 1mg syringe 10/box |
| Atropine |
| Atropine lmg/ml 25/box |
| Avelumab |
| Bavencio 20mg/ml 10ml |
| Azacitidine |
| Azacitidine 100mg |
| Bacteriostatic Water |
| Bacteriostatic Water 30ml 25/box |
| Bendamustine |
| Belrapzo (Eagle brand) 100mg |
| Bendamustine |
| Bendeka 100mg |
| Bendamustine |
| Treanda 100mg PWD |
| Bendamustine |
| Treanda 25mg PWD |
| Benralizumab |
| Fasenra 30mg Syr |
| Bevacizumab |
| Avastin 100mg |
| Bevacizumab |
| Avastin 400mg |
| Bevacizumab-AWWB |
| Mvasi 100mg |
| Bevacizumab-AWWB |
| Mvasi 400mg |
| Bevacizumab-BVZR |
| Zirabev 100mg |
| Bevacizumab-BVZR |
| Zirabev 400mg |
| Bezlotoxumab |
| Zinplava 1000mg |
| Blinatumomab |
| Blincyto 35mcg |
| Brentuximab Vedotin |
| Adcetris 50mg |
| Calcium Gluconate |
| Calcium Gluc 100mg 10% 10ml 25/box |
| Calcium Gluconate |
| Calcium Gluconate 10% 50ml 25/box |
| Carboplatin |
| Carboplatin 150mg |
| Carboplatin |
| Carboplatin 450mg |
| Carboplatin |
| Carboplatin 50mg |
| Carboplatin |
| Carboplatin 600mg |
| Carfilzomib |
| Kyprolis 30mg |
| Carfilzomib |
| Kyprolis 60mg |
| Carmustine in Polifeprosan |
| Gliadel Wafer |
| Cefazolin |
| Cefazolin 1gm 25/box |
| Cefepime |
| Cefepime 1gm 10/box |
| Ceftazidime |
| Ceftazidime 2gm 10/box |
| Ceftazidime |
| Tazicef 1gm 25/box |
| Ceftriaxone |
| Ceftriaxone 1 gm 10/box |
| Certolizumab |
| Cimzia 200mg Syr 2/box |
| Cisplatin |
| Cisplatin 100mg |
| Cladribine |
| Cladribine 10mg |
| Clindamycin |
| Clindamycin 300mg/50ml ea. |
| Clindamycin |
| Clindamycin 600mg/4ml ea. |
| Collagenase Clostridium Hist |
| Xiaflex 0.9mg vial |
| Cyanocobalamin |
| Cyanocobalamin 1000mcg/1ml 25/box |
| Cyclophosphamide |
| Cyclophosphamide 1gm |
| Cyclophosphamide |
| Cyclophosphamide 1gm |
| Cyclophosphamide |
| Cyclophosphamide 25mg (100 tabs) |
| Cyclophosphamide |
| Cyclophosphamide 2gm |
| Cyclophosphamide |
| Cyclophosphamide 500mg |
| Cyclophosphamide |
| Cyclophosphamide 50mg (100 tabs) |
| Cyclosporine |
| Cyclosporine 250mg/5ml 10/box |
| Cytarabine |
| Cytarabine 100mg 5/box |
| Cytarabine |
| Cytarabine 2gm |
| Cytarabine Liposomal |
| Depocyt 50mg |
| Dacarbazine |
| Dacarbazine 200mg 10/box |
| Dactinomycin |
| Cosmegen 0.5mg |
| Daratumumab |
| Darzalex 100MG |
| Daratumumab |
| Darzalex 400MG |
| Daunorubicin |
| Daunorubicin 20mg/4mL 10/box |
| Deferoxamine |
| Deferoxamine 500mg 4/box |
| Degarelix |
| Firmagon 240mg (2 x120) |
| Dexamethasone |
| Dexamethasone 10mg/mL 10mL 10/box |
| Dexamethasone |
| Dexamethasone 10mg/ml 1ml 25/box |
| Dexamethasone |
| Dexamethasone 4mg/ml 1ml 25/box |
| Dexamethasone |
| Ozurdex Implant 0.7mg Kit (DS item 1-2 days) |
| Dexrazoxane |
| Zinecard (Dexrazoxane) 500mg |
| Diphenhydramine |
| Diphenhydramine 50mg 25/box |
| Docetaxel |
| Docetaxel 160mg/8ml (20mg/ml) |
| Docetaxel |
| Docetaxel 20mg/2ml (10mg/mL) |
| Docetaxel |
| Docetaxel 80mg/8ml (10mg/mL) |
| Doxorubicin |
| Adriamycin 50mg |
| Doxorubicin |
| Doxorubicin 10mg 10/box |
| Doxorubicin |
| Doxorubicin 20mg |
| Doxorubicin |
| Doxorubicin 50mg |
| Doxorubicin |
| Doxorubicin 50mg |
| Enfortumab Vedotin EJFV |
| Padcev 30mg |
| Ep9etin |
| Epogen 10k unit 10/box |
| Epinepherine |
| Epinepherine 1:1000 25/box |
| Epinepherine |
| Epinepherine 30mg vial |
| Epirubicin |
| Epirubicin 200mg |
| Epirubicin |
| Epirubicin 50mg |
| Epoetin |
| Epogen 20k unit 10/box |
| Epoetin |
| Epogen 4k unit 10/box |
| Epoetin |
| Procrit 10k unit 6/box |
| Epoetin |
| Procrit 20k unit 4/box |
| Epoetin |
| Procrit 40k unit 4/box |
| Epoetin |
| Procrit 4k unit 6/box |
| Epoetin Alfa EPBX |
| Retacrit 10k unit 10/box |
| Epoetin Alfa EPBX |
| Retacrit 40k unit 4/box |
| Eribulin Mesylate |
| Halaven 1mg |
| Ertapenem |
| lnvanz 1gm 10/box |
| Etanercept |
| Enbrel Mini 50mg/0.98ml Cart |
| Etoposide |
| Etoposide 100mg |
| Etoposide |
| Etoposide 500mg |
| Famotidine |
| Famotidine 20mg 25/box |
| FAM-Trastuzumab-Deruxtecn-nxkiFAM |
| Enhertu 100mg pwd |
| Ferric Carboxymaltose |
| Injectafer 750mg |
| Ferric Gluconate |
| Ferric Gluconate 62.5mg 10/box |
| Ferumoxytol |
| Feraheme 510mg |
| Filgrastim |
| Neupogen 300mcg syringe 10/box |
| Filgrastim |
| Neupogen 480mcg syringe 10/box |
| Filgrastim AAFI 480mcg/0.8ml Syr each |
| Nivestym 480mcg/0.8ml Syr each |
| Filgrastim-Sndz |
| Zarxio 300mcg syringe ea. |
| Filgrastim-Sndz |
| Zarxio 480mcg syringe ea. |
| Floxuradine |
| Floxuradine 500mg |
| Fludarabine |
| Fludarabine 50mg |
| Fluorouracil |
| Fluorouracil 1gm 10/box |
| Fluorouracil |
| Fluorouracil 2.5gm |
| Fluorouracil |
| Fluorouracil 500mg 10/box |
| Fluorouracil |
| Fluorouracil 5gm |
| Fosaprepitant |
| Emend 150mg |
| Foscarnet Sodium |
| Foscavir Ggm 10/box |
| Fulvestrant |
| Faslodex 250mg 2/box |
| Furosemide |
| Furosemide 100mg vial 25/box |
| Furosemide |
| Furosemide 20mg 25/box |
| Ganciclovir |
| Ganciclovir 500mg (Cytovene) 25/box |
| Gemcitabine |
| Gemcitabine 1gm |
| Gemcitabine |
| Gemcitabine 1gm (100mg/ml 10ml) |
| Gemcitabine |
| Gemcitabine 200mg |
| Gemcitabine |
| Gemcitabine 200mg (100mg/ml 2ml) |
| Gemcitabine |
| Gemcitabine 2gm |
| Gemtuzumab Ozogamicin |
| Mylotarg 4.5mg |
| Gentamicin Sulfate |
| Gentamicin 80mg 25/box |
| Golimumab |
| Simponi Aria 12.5mg/ml 4ml |
| Granisetron |
| Granisetron Hydrochloride 1mg |
| Granisetron |
| Granisetron Hydrochloride 4mg |
| Heparin Sodium |
| Heparin Sodium 1000u/ml 1ml 25/box |
| Hyaluronate Sodium |
| Euflexxa 1% 20mg/2ml (20mg) syringe 3x2ml |
| Hyaluronate Sodium |
| Gel-One 30mg/3ml Syringe |
| Hyaluronate Sodium |
| Gelsyn-3, 8.4mg/ml 2ml syringe |
| Hyaluronate Sodium |
| Hyalgan 20mg/2ml syringe |
| Hyaluronate Sodium |
| Monovisc 22mg/ml 4ml Syringe |
| Hyaluronate Sodium |
| Orthovisc 30mg/2ml Syringe |
| Hyaluronate Sodium |
| Supartz 25mg/2.5ml Syringe |
| Hyaluronate Sodium |
| Synvisc 16mg/2ml 3x2ml Syringe |
| Hyaluronate Sodium |
| Synvisc-One 48mg/6ml Syringe |
| Hyaluronate Sodium |
| Visco-3 10mg/ml 3x 2.5ml Syringe |
| Hydrocortisone |
| Solu-Cortef 100mg |
| Idarubicin |
| Idarubicin 10mg |
| Idarubicin |
| Idarubicin 20mg |
| Idarubicin |
| Idarubicin 5mg |
| Ifosfamide |
| Ifosfamide 1gm |
| Immune Globulin IVIG |
| Octagam 10% 10gm |
| Immune Globulin IVIG |
| Octagam 10% 20gm |
| Immune Globulin IVIG |
| Octagam 10% 2gm |
| Immune Globulin IVIG |
| Octagam 10% 5gm |
| Incobotulinumtoxin A |
| Xeomin PR 200u PF |
| Infliximab |
| Remicade 100mg |
| Infliximab-ABDA |
| Renflexis 100mg |
| Infliximab-DYYB |
| lnflectra 100mg |
| Interferon alfa 2-b |
| lntron A l0mu |
| Iohexal |
| Omnipaque 300mg/50ml 10/box |
| Iopamidol |
| lsovue-300mg 61% 10x30ml |
| Irinotecan |
| Irinotecan 100mg |
| Irinotecan |
| Irinotecan 40mg |
| Iron Dextran |
| Infed 100mg 10/box |
| Iron Sucrose |
| Venofer 100mg 10/box |
| Iron Sucrose |
| Venofer 200mg 5/box |
| IVIG |
| ·Gamma gard 1gm vial |
| IVIG |
| Atgam S0mg/ml SxSml amp |
| Leucovorin |
| Leucovorin 100mg |
| Leucovorin |
| Leucovorin 350mg |
| Leuprolide Acetate |
| Eligard 22.5mg |
| Leuprolide Acetate |
| Eligard 30mg |
| Leuprolide Acetate |
| Eligard 45mg |
| Leuprolide Acetate |
| Eligard 7.5mg |
| Leuprolide Acetate |
| Leuprolide 14mg 2.8ml 14 day kit |
| Leuprolide Acetate |
| Lupron Depot 11.25mg |
| Leuprolide Acetate |
| Lupron Depot 3.75mg |
| Levoleucovorin |
| Fusilev 50mg |
| Lidocaine |
| Lidocaine 4% 40mg/ml 25x5ml |
| Liposomal Doxorubicin |
| Liposomal Doxorubicin 20mg |
| Liposomal Doxorubicin |
| Liposomal Doxorubicin 50mg |
| Liposomal Irinotecan |
| Onivyde 4.3mg/ml 10ml |
| Lorazepam |
| Lorazepam 2mg/1mL 10/box |
| Lurbinectedin |
| Zepzelca 4mg |
| Magnesium Sulfate |
| Magnesium Sulfate 1gm/2mL 25/box |
| Mannitol |
| Mannitol 25% 50mL each 25/box |
| Mechlorethamine |
| Mechlorethamine 10mg 4/box |
| Methotrexate |
| Methotrexate 50mg PF 10/box |
| Methotrexate |
| Methotrexate PF 1gm |
| Methotrexate |
| Methotrexate PF 250mg 10ml |
| Methylene Blue |
| Provayblue 0.5% Sx10ml |
| Methylprednisolone |
| Solu-Medrol (A-Methapred) 125mg 25/box |
| Methylprednisolone |
| Solu-Medrol (Methylprednisolone 40mg) x25 |
| Metoclopramide |
| Metoclopramide 10mg 25/box |
| Mitoxantrone |
| Novantrone 20mg |
| Mitoxantrone |
| Novantrone 25mg |
| Mycophenolate Mofetil |
| Cellcept 500mg 4x20ml |
| Naltrexone |
| Vivitrol 380mg |
| Natalizumab |
| Tysabri 300mg |
| Nelarabine |
| Arranon SF 250mg 6/box |
| Nivolumab |
| Opdivo 100mg/10ml SDPF |
| Nivolumab |
| Opdivo 240mg/10ml SDPF |
| Nivolumab |
| Opdivo 40mg/4ml SDPF |
| Normal Saline |
| 0.9% NACL 50ml 25/box |
| Obinutuzumab |
| Gazyva 1000mg/40ml SDV PF |
| Ocrelizumab |
| Ocrevus 300mg |
| Octreotide |
| Octreotide 100mcg 10/box |
| Octreotide |
| Sandostatin LAR 10mg |
| Octreotide |
| Sandostatin LAR 20mg |
| Octreotide |
| Sandostatin LAR 30mg |
| Ofatumumab | |
| Arzerra 20mg/ml 3x5ml | ' |
| Ofatumumab |
| Arzerra 20mg/ml lxS0ml |
| Omalizumab |
| Xolair 150mg Syringe |
| Omalizumab |
| Xolair 75mg Syringe |
| Onabotulinumtoxina |
| Botox 100iu (drop ship - dr info req) |
| Ondansetron |
| Ondansetron 40mg |
| Ondansetron |
| Ondansetron 4mg 25/box |
| Oxaliplatin |
| Oxaliplatin 100mg |
| Oxaliplatin |
| Oxaliplatin 50mg |
| Paclitaxel |
| Paclitaxel 100mg |
| Paclitaxel |
| Paclitaxel 300mg |
| Paclitaxel |
| Paclitaxel 30mg |
| Palifermin |
| Kepivance 6.25mg/ml 3/box |
| Palonosetron |
| Palonosetron 0.25mg |
| Pamidronate |
| Pamidronate 30mg |
| Pamidronate |
| Pamidronate 90mg |
| PB Paclitaxel |
| Abraxane 100mg |
| Pegasparaginase |
| Oncaspar 3,750 units |
| Pegfilgrastim |
| Fulphila 6mg/0.6ml syringe |
| Pegfilgrastim |
| Neulasta 6mg syringe |
| Pegfilgrastim |
| Neulasta Onpro Delivery Kit 6mg |
| Pegfilgrastim |
| Udenyca 6mg/0.6ml syringe |
| Pembrolizumab |
| Keytruda 100mg |
| Pembrolizumab |
| Keytruda 100mg x2 |
| Pentamidine Isethionate |
| Pentam 300mg 10/box |
| Pentamidine lsethionate |
| Nebupent 300mg |
| Polatuzumab Vedotin-PIIQ |
| Polivy 30mg |
| Potassium |
| Potassium Chloride 20meq 25/box |
| Pralatrexate |
| Folotyn 20mg |
| Pralatrexate |
| Folotyn 40mg |
| Prochlorperazine |
| Prochlorperazine Edisylate 10mg 10/box |
| Promethazine |
| Promethazine 25mg 25/box |
| Ramucirumab |
| Cyramza 100mg |
| Ramucirumab |
| Cyramza 500mg |
| Ranibizumab |
| Lucentis .3mg/.05ml vial |
| Ranibizumab |
| Lucentis .5mg/.0SmL vial |
| Ranitidine |
| Ranitidine 50mg/2ml 10/box |
| Rasburicase |
| Elitek 1.5mg 3/box |
| Rasburicase |
| Elitek 7.5mg vial |
| Rimabotulinumtoxinb |
| Myobloc 5000u/ml 1ml |
| Risankizumab-RZAA |
| Skyrizi 75mg/0.83ml |
| Rituximab-ABBS |
| Truxima 100mg |
| Rituximab-ABBS |
| Truxima 500mg |
| Rituximab-PVVR |
| Ruxience 100mg |
| Rituximab-PVVR |
| Ruxience 500mg |
| Romiplostim |
| Nplate 250mcg |
| Romiplostim |
| Nplate 500mcg |
| Sodium Bicarbonate |
| Sodium Bicarbonate 8.4% 50ml syr 10/box |
| Sodium Bicarbonate |
| Sodium Bicarbonate 8.4% 50meq vial 25/box |
| Tacrolimus |
| Prograf 5mg/ml 1ml PF Amp 10/box |
| Tbo-Filgrastim |
| Granix 300mcg Syringe x1 |
| Tbo-Filgrastim |
| Granix 480 mcg Syringe x1 |
| Temsirolimus |
| Torisel 25mg |
| Testosterone |
| Depo-Testosterone 200mg/10ml |
| Tetracaine |
| Tetracaine .5% OPHT Sol 12/box |
| Thyrotropin |
| Thyrogen 1.1mg x2 |
| Tocilizumab |
| Actemra 200mg |
| Tocilizumab |
| Actemra 400mg |
| Trastuzumab |
| Herceptin 150mg |
| Trastuzumab-ANNS |
| Kanjinti 150mg |
| Trastuzumab-ANNS· |
| Kanjinti 420mg |
| Trastuzumab-QYYP |
| Trazimera 420mg |
| Triamcinalone PF |
| Triesence 40mg/1ml PF |
| Triptorelin |
| Trelstar 3.75mg |
| Ustekinumab |
| Sterlara 130mg Smg/ml 26ml |
| Valrubicin |
| Valstar 40mg/ml 5ml SDV 4/box |
| Vancomycin |
| Vancomycin 1gm 10/box |
| Vedolizumab |
| Entyvio 300mg 20ml SDV |
| Vinblastine |
| Vinblastine 10mg |
| Vincristine |
| Vincristine 1mg |
| Vincristine |
| Vincristine 2mg |
| Vinorelbine |
| Vinorelbine 10mg |
| Vinorelbine |
| Vinorelbine 50mg |
| Water |
| Sterile Water 10ml 25/box |
| Water |
| Sterile Water 50ml 25/box |
| Ziv-Afilbercept |
| Zaltrap 100mg |
| Ziv-Afilbercept |
| Zaltrap 200mg |
| Zoledronic Acid |
| Zoledronic Acid 4mg/5ml (Generic Zometa) |
| Zoledronic Acid |
| Zoledronic Acid 5mg (Generic Reclast) |
B.3 PRICE/COST SCHEDULE
ITEM INFORMATION
| ITEM NUMBER |
| DESCRIPTION OF SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| 52.00 |
| WK |
| __________________ |
| __________________ |
Compounded Chemotherapy Drugs Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals
| GRAND TOTAL |
| __________________ |
B.4 DELIVERY SCHEDULE
| ITEM NUMBER |
| QUANTITY |
| DELIVERY DATE |
| 0001 |
| SHIP TO: |
| Department of Veterans Affairs |
VA Long Beach Healthcare System 5901 East 7th Street BLDG 149 Long Beach, CA 90822
USA
52.00
Page of
SECTION C - CONTRACT CLAUSES
| 52.203-17 |
| CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS |
| JUN 2020 |
| 52.204-4 |
| PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER CONTENT PAPER |
| MAY 2011 |
| 52.204-13 |
| SYSTEM FOR AWARD MANAGEMENT MAINTENANCE |
| OCT 2018 |
C.1 52.204-27 PROHIBITION ON A BYTEDANCE COVERED APPLICATION (JUN 2023)
(a) Definitions. As used in this clause— Covered application means the social networking service TikTok or any successor application or service developed or provided by ByteDance Limited or an entity owned by ByteDance Limited.
Information technology, as defined in 40 U.S.C. 11101(6)—
(1) Means any equipment or interconnected system or subsystem of equipment, used in the automatic acquisition, storage, analysis, evaluation, manipulation, management, movement, control, display, switching, interchange, transmission, or reception of data or information by the executive agency, if the equipment is used by the executive agency directly or is used by a contractor under a contract with the executive agency that requires the use—
(i) Of that equipment; or
(ii) Of that equipment to a significant extent in the performance of a service or the furnishing of a product;
(2) Includes computers, ancillary equipment (including imaging peripherals, input, output, and storage devices necessary for security and surveillance), peripheral equipment designed to be controlled by the central processing unit of a computer, software, firmware and similar procedures, services (including support services), and related resources; but
(3) Does not include any equipment acquired by a Federal contractor incidental to a Federal contract.
(b) Prohibition. Section 102 of Division R of the Consolidated Appropriations Act, 2023 (Pub. L. 117–328), the No TikTok on Government Devices Act, and its implementing guidance under Office of Management and Budget (OMB) Memorandum M–23–13, dated February 27, 2023, ‘‘No TikTok on Government Devices’’ Implementation Guidance, collectively prohibit the presence or use of a covered application on executive agency information technology, including certain equipment used by Federal contractors. The Contractor is prohibited from having or using a covered application on any information technology owned or managed by the Government, or on any information technology used or provided by the Contractor under this contract, including equipment provided by the Contractor’s employees; however, this prohibition does not apply if the Contracting Officer provides written notification to the Contractor that an exception has been granted in accordance with OMB Memorandum M–23–13.
(c) Subcontracts. The Contractor shall insert the substance of this clause, including this paragraph (c), in all subcontracts, including subcontracts for the acquisition of commercial products or commercial services.
(End of Clause)
| 52.204-18 |
| COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE |
| AUG 2020 |
C.2 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022)
(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—
(1) Within a reasonable time after the defect was discovered or should have been discovered; and
(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.
(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.
(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.
(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.
(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.
(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.
(g) Invoice.
(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—
(i) Name and address of the Contractor;
(ii) Invoice date and number;
(iii) Contract number, line item number and, if applicable, the order number;
(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;
(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;
(vi) Terms of any discount for prompt payment offered;
(vii) Name and address of official to whom payment is to be sent;
(viii) Name, title, and phone number of person to notify in event of defective invoice; and
(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.
(x) Electronic funds transfer (EFT) banking information.
(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.
(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.
(C) EFT banking information is not required if the Government waived the requirement to pay by EFT.
(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.
(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.
(i) Payment.—
(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.
(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.
(3) Electronic Funds Transfer (EFT). If the Government makes payment by EFT, see 52.212-5(b) for the appropriate EFT clause.
(4) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date which appears on the payment check or the specified payment date if an electronic funds transfer payment is made.
(5) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—
(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—
(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);
(B) Affected contract number and delivery order number, if applicable;
(C) Affected line item or subline item, if applicable; and
(D) Contractor point of contact.
(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.
(6) Interest.
(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.
(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.
(iii) Final decisions. The Contracting Officer will issue a final decision as required by 33.211 if—
(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;
(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or
(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see 32.607-2).
(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.
(v) Amounts shall be due at the earliest of the following dates:
(A) The date fixed under this contract.
(B) The date of the first written demand for payment, including any demand for payment resulting from a default termination.
(vi) The interest charge shall be computed for the actual number of calendar days involved beginning on the due date and ending on—
(A) The date on which the designated office receives payment from the Contractor;
(B) The date of issuance of a Government check to the Contractor from which an amount otherwise payable has been withheld as a credit against the contract debt; or
(C) The date on which an amount withheld and applied to the contract debt would otherwise have become payable to the Contractor.
(vii) The interest charge made under this clause may be reduced under the procedures prescribed in FAR 32.608-2 in effect on the date of this contract.
(j) Risk of loss. Unless the contract specifically provides otherwise, risk of loss or damage to the supplies provided under this contract shall remain with the Contractor until, and shall pass to the Government upon:
(1) Delivery of the supplies to a carrier, if transportation is f.o.b. origin; or
(2) Delivery of the supplies to the Government at the destination specified in the contract, if transportation is f.o.b. destination.
(k) Taxes. The contract price includes all applicable Federal, State, and local taxes and duties.
(l) Termination for the Government's convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor's records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.
(m) Termination for cause. The Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.
(n) Title. Unless specified elsewhere in this contract, title to items furnished under this contract shall pass to the Government upon acceptance, regardless of when or where the Government takes physical possession.
(o) Warranty. The Contractor warrants and implies that the items delivered hereunder are merchantable and fit for use for the particular purpose described in this contract.
(p) Limitation of liability. Except as otherwise provided by an express warranty, the Contractor will not be liable to the Government for consequential damages resulting from any defect or deficiencies in accepted items.
(q) Other compliances. The Contractor shall comply with all applicable Federal, State and local laws, executive orders, rules and regulations applicable to its performance under this contract.
(r) Compliance with laws unique to Government contracts. The Contractor agrees to comply with 31 U.S.C. 1352 relating to limitations on the use of appropriated funds to influence certain Federal contracts; 18 U.S.C. 431 relating to officials not to benefit; 40 U.S.C. chapter 37, Contract Work Hours and Safety Standards; 41 U.S.C. chapter 87, Kickbacks; 41 U.S.C. 4712 and 10 U.S.C. 4701 relating to whistleblower protections; 49 U.S.C. 40118, Fly American; and 41 U.S.C. chapter 21 relating to procurement integrity.
(s) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:
(1) The schedule of supplies/services.
(2) The Assignments, Disputes, Payments, Invoice, Other Compliances, Compliance with Laws Unique to Government Contracts, and Unauthorized Obligations paragraphs of this clause;
(3) The clause at 52.212-5.
(4) Addenda to this solicitation or contract, including any license agreements for computer software.
(5) Solicitation provisions if this is a solicitation.
(6) Other paragraphs of this clause.
(7) The Standard Form 1449.
(8) Other documents, exhibits, and attachments
(9) The specification.
(t) [Reserved]
(u) Unauthorized Obligations.
(1) Except as stated in paragraph (u)(2) of this clause, when any supply or service acquired under this contract is subject to any End User License Agreement (EULA), Terms of Service (TOS), or similar legal instrument or agreement, that includes any clause requiring the Government to indemnify the Contractor or any person or entity for damages, costs, fees, or any other loss or liability that would create an Anti-Deficiency Act violation (31 U.S.C. 1341), the following shall govern:
(i) Any such clause is unenforceable against the Government.
(ii) Neither the Government nor any Government authorized end user shall be deemed to have agreed to such clause by virtue of it appearing in the EULA, TOS, or similar legal instrument or agreement. If the EULA, TOS, or similar legal instrument or agreement is invoked through an “I agree” click box or other comparable mechanism (e.g., “click-wrap” or “browse-wrap” agreements), execution does not bind the Government or any Government authorized end user to such clause.
(iii) Any such clause is deemed to be stricken from the EULA, TOS, or similar legal instrument or agreement.
(2) Paragraph (u)(1) of this clause does not apply to indemnification by the Government that is expressly authorized by statute and specifically authorized under applicable agency regulations and procedures.
(v) Incorporation by reference. The Contractor’s representations and certifications, including those completed electronically via the System for Award Management (SAM), are incorporated by reference into the contract.
(End of Clause) ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.
The following clauses are incorporated into 52.212-4 as an addendum to this contract:
(End of Addendum to 52.212-4)
C.3 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):
https://www.acquisition.gov/browse/index/far https://www.va.gov/oal/library/vaar/
(End of Clause)
| 852.203-70 |
| COMMERCIAL ADVERTISING |
| MAY 2018 |
C.4 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018)
(a) The Contractor shall conform to the standards established by: Food and Drug Administration/Department of Transportation as to manufacturing and delivery of radiopharmaceuticals.
(b) The Contractor shall submit proof of conformance to the standard. This proof may be a label or seal affixed to the equipment or supplies, warranting that the item(s) have been tested in accordance with the standards and meet the contract requirement. Proof may also be furnished by the organization listed above certifying that the item(s) furnished have been tested in accordance with and conform to the specified standards.
(c) Offerors may obtain the standards cited in this provision by submitting a request, including the solicitation number, title and number of the publication to: Food and Drug Administration/Department of Transportation
(d) The offeror shall contact the Contracting Officer if response is not received within two weeks of the request.
(End of Clause)
| 852.215-70 |
| SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTORS (DEVIATION) |
| JAN 2023 |
| 852.215-71 |
| EVALUATION FACTOR COMMITMENTS |
| OCT 2019 |
C.5 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)
(a) Definitions. As used in this clause—
(1) Contract financing payment has the meaning given in FAR 32.001;
(2) Designated agency office means the office designated by the purchase order, agreement, or contract to first receive and review invoices. This office can be contractually designated as the receiving entity. This office may be different from the office issuing the payment;
(3) Electronic form means an automated system transmitting information electronically according to the accepted electronic data transmission methods and formats identified in paragraph (c) of this clause. Facsimile, email, and scanned documents are not acceptable electronic forms for submission of payment requests;
(4) Invoice payment has the meaning given in FAR 32.001; and
(5) Payment request means any request for contract financing payment or invoice payment submitted by the contractor under this contract.
(b) Electronic payment requests. Except as provided in paragraph (e) of this clause, the contractor shall submit payment requests in electronic form. Purchases paid with a Government-wide commercial purchase card are considered to be an electronic transaction for purposes of this rule, and therefore no additional electronic invoice submission is required.
(c) Data transmission. A contractor must ensure that the data transmission method and format are through one of the following:
(1) VA’s Electronic Invoice Presentment and Payment System at the current website address provided in…
This is the start of the file's text. The full file is on GovTribe.